Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People (NOT-OD-22-166)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed) (PAR-22-221)

Sponsor: National Institute of Neurological Disorders and Stroke National Institute on Aging

Award: The NINDS has committed $1,000,000 to fund up to two awards.

Due Date: October 05, 2022. All applications are due by 5:00 PM local time of applicant organization.

Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (UH2/UH3 Clinical Trial Not Allowed) (RFA-AG-23-020)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2.8 million in fiscal year 2023 to fund five awards.

Due Date: October 21, 2022. All applications are due by 5:00 PM local time of applicant organization.

Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed) (RFA-NS-22-062)

Sponsor: National Institute of Neurological Disorders and Stroke National Institute on Aging

Award: NINDS intends to fund up to 2 awards, corresponding to $2,000,000 total costs for fiscal year 2023.

Due Date: November 04, 2022. All applications are due by 5:00 PM local time of applicant organization.

Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimers Disease and AD-Related Dementias (NOT-AG-22-020)

Sponsor: National Institute on Aging

Due Date: December 9, 2022 and June 9, 2023, by 5:00 PM local time of applicant organization.

Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional) (RFA-AG-23-026)

Sponsor: National Institute on Aging

Award: NIA intends to commit approximately $4 million to fund 5 to 8 competing awards in fiscal year 2023.

Due Date: October 21, 2022. All applications are due by 5:00 PM local time of applicant organization.

Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional) (RFA-AG-23-027)

Sponsor: National Institute on Aging

Award: NIA intends to commit a total of $800,000 in fiscal year 2023 to fund one award.

Due Date: October 21, 2022. All applications are due by 5:00 PM local time of applicant organization.

Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed) (RFA-NS-22-059)

Sponsor: National Institute of Neurological Disorders and Stroke National Institute on Aging

Due Date: October 31, 2022. All applications are due by 5:00 PM local time of applicant organization.

Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional) (RFA-OD-22-014)

Sponsor: National Institutes of Health

Due Date: Multiple due dates, see announcement.

Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional) (RFA-AG-23-025)

Sponsor: National Institute on Aging

Award: NIA intends to commit approximately $6.4 million to fund 7 to 9 competing awards in fiscal year 2023.

Due Date: October 21, 2022. All applications are due by 5:00 PM local time of applicant organization.

Notice of Intent to Publish a Funding Opportunity Announcement for Resource-Related Research Projects for Development of Animal Models and Related Materials (NOT-OD-22-188)

Sponsor: National Institutes of Health

Geroscience Course (R25 Independent Clinical Trial Not Allowed) (PAR-22-214)

Sponsor: National Institutes of Health

Award: Application budgets are limited to $250,000 in direct costs per year. The maximum project period is 3 years.

Due Date: October 21, 2022. All applications are due by 5:00 PM local time of applicant organization.

Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed) (PAR-23-023)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: NINDS intends to commit $3,750,000 in FY 2023 to fund up to five awards.

Due Date: October 24, 2022. All applications are due by 5:00 PM local time of applicant organization.

BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) (RFA-MH-22-240)

Sponsor: National Institutes of Health

Award: NIMH and partner components intend to commit an estimated total of $10 million to fund 8-10 awards in FY2024 and an estimated total of $10 million to fund 8-10 awards in FY2025.

Due Date: Multiple due dates; see announcement.

Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed) (RFA-NS-22-055)

Sponsor: National Institute of Neurological Disorders and Stroke National Institute on Aging

Award: NIH intends to commit up to $2,700,000 to fund up to 3 awards for the R61 phase. For the R33 phase, the NIH intends to commit up to $4,500,000.

Due Date: November 08, 2022. All applications are due by 5:00 PM local time of applicant organization.